# FDA 483 - Continental Services Group, Inc. - August 24, 2022

Source: https://www.keypedia.com/records/483/continental-services-group-inc/d16846a7-a1fc-4aa6-9f0c-8596435a2d9c

> FDA 483 for Continental Services Group, Inc. on August 24, 2022. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Continental Services Group, Inc.
- Inspection Date: 2022-08-24
- Product Type: biologics
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: An FDA inspection of Continental Services Group, Inc., a blood bank and plasma center in Ft Lauderdale, revealed two significant observations. The firm failed to maintain adequate donor and general records, specifically regarding software validation for donor screening. Additionally, the inspection found that the firm did not make reasonable attempts to notify donors of positive HIV and HCV test results within the required timeframe.

## Related Documents

- [483 - 2019-05-31](https://www.keypedia.com/records/483/continental-services-group-inc/a8f9cea7-4c61-4432-ab85-29aed63ca20b)
- [483 - 2022-08-24](https://www.keypedia.com/records/483/continental-services-group-inc/bdbb942d-1cd5-4dd5-96d7-671470809563)
- [483 - 2024-07-24](https://www.keypedia.com/records/483/continental-services-group-inc/885d8156-1b3b-4828-9cda-ee165dc4f38f)

## Related Officers

- [Sergio E. Delgado](https://www.keypedia.com/people/sergio-e-delgado/5edfee62-05aa-44aa-9161-def8f31d3ea2)
- [Laura E. Garcia](https://www.keypedia.com/people/laura-e-garcia/ad7c9bee-bbff-494f-b9cf-35c3a04316c0)
- [Annette Melendez](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)

Company: https://www.keypedia.com/companies/continental-services-group-inc/72358f1d-9b15-4d27-87c5-434e7b5f27d1

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6